Related Experiment Video
Updated: Sep 14, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
The discriminative stimulus properties of the 5HT1 agonist RU24969
1Roussel Laboratories, Swindon, Wiltshire, England.
Abstract:
Using standard operant procedures, rats were trained to discriminate the 5-HT agonist RU24969 (0.5 mg/kg IP) from saline. Stable responding was established and tests of stimulus generalisation and stimulus antagonism were performed with a range of 5-HT receptor ligands. The RU24969 cue was selective as neither 5-HT receptor ligands MK212, DPAT, ipsapirone, GR38032F or the 5-HT releasing agent, fenfluramine nor yohimbine were able to substitute for RU24969 in tests of generalisation. However, TFMPP, CPP and, of particular interest, propranolol substituted for the RU24969 stimulus, although full substitution only occurred with doses that disrupted responding. The RU24969 stimulus was not antagonised by propranolol, metergoline, ritanserin or GR38032F. This pharmacological profile suggests that the RU24969 stimulus is mediated via a subtype of 5-HT1 sites different from 5-HT1A and that propranolol may be an agonist at this site.
More Related Videos
Related Concept Videos
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

